Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2025-12-15 00:00:00 ET · period of report 2025-12-11 · accession 0001193125-25-319553 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-15 | 2025-12-11+ | LMAT | LeMaitre George W | COB, CEO, Dir | M - OptEx | $47.18 | +26.3K | 1.70M | +2% | +$1.24M |
| DM | 2025-12-15 | 2025-12-11+ | LMAT | LeMaitre George W | COB, CEO, Dir | F - Tax | $83.79 | -1,978 | 1.68M | -0.1% | -$165.7K |
| D | 2025-12-15 | 2025-12-12 | LMAT | LeMaitre George W | COB, CEO, Dir | G - Gift | $0.00 | -12.1K | 1.68M | -0.7% | $0 |
| DI | 2025-12-15 | 2025-12-12 | LMAT | LeMaitre George W | COB, CEO, Dir | A - Grant | $0.00 | +12.1K | 33.4K | +57% | $0 |
| DM | 2025-12-15 | 2025-12-11+ | LMAT | LeMaitre George W | COB, CEO, Dir | M - OptEx | $0.00 | -26.3K | 9,194 | -74% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | M | A | 54 | $0.00 | 1,670,159 | D LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. (F4) These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2025-12-11 | F | D | 652 | $83.36 | 1,669,507 | D | — | — | (F2) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 3 | Common | Common Stock | 2025-12-12 | M | A | 5,155 | $37.29 | 1,674,662 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 4 | Common | Common Stock | 2025-12-12 | M | A | 7,733 | $48.60 | 1,682,395 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 5 | Common | Common Stock | 2025-12-12 | M | A | 7,075 | $47.19 | 1,689,470 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 6 | Common | Common Stock | 2025-12-12 | F | D | 663 | $84.00 | 1,682,304 | D | — | — | (F6) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 7 | Common | Common Stock | 2025-12-12 | G | D | 12,100 | $0.00 | 1,683,552 | D | — | — | |
| 8 | Common | Common Stock | 2025-12-12 | A | A | 12,100 | $0.00 | 33,400 | I | — | — | |
| 9 | Common | Common Stock | 2025-12-12 | M | A | 39 | $0.00 | 1,683,591 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 10 | Common | Common Stock | 2025-12-12 | F | D | 663 | $84.00 | 1,682,928 | D | — | — | (F5) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 11 | Common | Common Stock | 2025-12-12 | M | A | 39 | $0.00 | 1,682,967 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 12 | Common | Common Stock | 2025-12-12 | M | A | 6,182 | $54.65 | 1,695,652 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 13 | Derivative | Dividend Equivalent Rights | 2025-12-11 | M | D | 54 | $0.00 | 0 | D | — · — to — | 54 Common Stock | (F7) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. (F8) Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero. |
| 14 | Derivative | Stock Option (Right to Buy) | 2025-12-12 | M | D | 5,155 | $0.00 | 0 | D | $37.29 · 2020-12-02 to 2027-12-02 | 5,155 Common Stock | (F9) This option is fully vested and exercisable. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-12-12 | M | D | 7,733 | $0.00 | 0 | D | $48.60 · 2021-12-11 to 2028-12-11 | 7,733 Common Stock | (F9) This option is fully vested and exercisable. |
| 16 | Derivative | Dividend Equivalent Rights | 2025-12-12 | M | D | 39 | $0.00 | 41.22 | D | — · — to — | 39 Common Stock | (F12) These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| 17 | Derivative | Stock Option (Right to Buy) | 2025-12-12 | M | D | 6,182 | $0.00 | 14,191 | D | $54.65 · 2023-12-08 to 2030-12-08 | 6,182 Common Stock | (F10) This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. |
| 18 | Derivative | Dividend Equivalent Rights | 2025-12-12 | M | D | 39 | $0.00 | 41.93 | D | — · — to — | 39 Common Stock | (F11) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| 19 | Derivative | Stock Option (Right to Buy) | 2025-12-12 | M | D | 7,075 | $0.00 | 9,194 | D | $47.19 · 2022-12-12 to 2029-12-12 | 7,075 Common Stock | (F10) This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. |